UnitedHealth Group Incorporated $UNH Shares Sold by Trust Investment Advisors

Trust Investment Advisors lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,220 shares of the healthcare conglomerate’s stock after selling 221 shares during the quarter. Trust Investment Advisors’ holdings in UnitedHealth Group were worth $1,004,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. boosted its position in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Bank of New York Mellon Corp increased its position in shares of UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares in the last quarter. Nuveen LLC purchased a new stake in UnitedHealth Group during the 1st quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. grew its position in shares of UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after purchasing an additional 847,054 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Bank of America boosted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Oppenheimer reduced their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Stock Up 1.0%

Shares of NYSE:UNH opened at $365.97 on Tuesday. The firm has a 50 day simple moving average of $339.58 and a 200-day simple moving average of $334.29. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $331.45 billion, a PE ratio of 15.86, a P/E/G ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 EPS. The business’s revenue was up 12.9% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.